The present invention is directed to compounds of Formula I, andpharmaceuticalcompositions thereof, which are inhibitors of intestinal apicalsodium/phosphateco-transport and are useful in the treatment of hyperphosphatemia, in reducingbloodphosphate levels, and in treating hypertension.(see formula I)